81 related articles for article (PubMed ID: 24530449)
1. CHF5074 and LY450139 sub-acute treatments differently affect cortical extracellular glutamate levels in pre-plaque Tg2576 mice.
Beggiato S; Giuliani A; Sivilia S; Lorenzini L; Antonelli T; Imbimbo BP; Giardino L; Calzà L; Ferraro L
Neuroscience; 2014 Apr; 266():13-22. PubMed ID: 24530449
[TBL] [Abstract][Full Text] [Related]
2. CHF5074 restores visual memory ability and pre-synaptic cortical acetylcholine release in pre-plaque Tg2576 mice.
Giuliani A; Beggiato S; Baldassarro VA; Mangano C; Giardino L; Imbimbo BP; Antonelli T; Calzà L; Ferraro L
J Neurochem; 2013 Mar; 124(5):613-20. PubMed ID: 23278303
[TBL] [Abstract][Full Text] [Related]
3. CHF5074 (CSP-1103) induces microglia alternative activation in plaque-free Tg2576 mice and primary glial cultures exposed to beta-amyloid.
Porrini V; Lanzillotta A; Branca C; Benarese M; Parrella E; Lorenzini L; Calzà L; Flaibani R; Spano PF; Imbimbo BP; Pizzi M
Neuroscience; 2015 Aug; 302():112-20. PubMed ID: 25450955
[TBL] [Abstract][Full Text] [Related]
4. The γ-secretase modulator CHF5074 restores memory and hippocampal synaptic plasticity in plaque-free Tg2576 mice.
Balducci C; Mehdawy B; Mare L; Giuliani A; Lorenzini L; Sivilia S; Giardino L; Calzà L; Lanzillotta A; Sarnico I; Pizzi M; Usiello A; Viscomi AR; Ottonello S; Villetti G; Imbimbo BP; Nisticò G; Forloni G; Nisticò R
J Alzheimers Dis; 2011; 24(4):799-816. PubMed ID: 21321397
[TBL] [Abstract][Full Text] [Related]
5. 1-(3',4'-Dichloro-2-fluoro[1,1'-biphenyl]-4-yl)-cyclopropanecarboxylic acid (CHF5074), a novel gamma-secretase modulator, reduces brain beta-amyloid pathology in a transgenic mouse model of Alzheimer's disease without causing peripheral toxicity.
Imbimbo BP; Del Giudice E; Colavito D; D'Arrigo A; Dalle Carbonare M; Villetti G; Facchinetti F; Volta R; Pietrini V; Baroc MF; Serneels L; De Strooper B; Leon A
J Pharmacol Exp Ther; 2007 Dec; 323(3):822-30. PubMed ID: 17895400
[TBL] [Abstract][Full Text] [Related]
6. CHF5074, a novel gamma-secretase modulator, restores hippocampal neurogenesis potential and reverses contextual memory deficit in a transgenic mouse model of Alzheimer's disease.
Imbimbo BP; Giardino L; Sivilia S; Giuliani A; Gusciglio M; Pietrini V; Del Giudice E; D'Arrigo A; Leon A; Villetti G; Calzà L
J Alzheimers Dis; 2010; 20(1):159-73. PubMed ID: 20164581
[TBL] [Abstract][Full Text] [Related]
7. Multi-target action of the novel anti-Alzheimer compound CHF5074: in vivo study of long term treatment in Tg2576 mice.
Sivilia S; Lorenzini L; Giuliani A; Gusciglio M; Fernandez M; Baldassarro VA; Mangano C; Ferraro L; Pietrini V; Baroc MF; Viscomi AR; Ottonello S; Villetti G; Imbimbo BP; Calzà L; Giardino L
BMC Neurosci; 2013 Apr; 14():44. PubMed ID: 23560952
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo profiling of CHF5022 and CHF5074 Two beta-amyloid1-42 lowering agents.
Imbimbo BP; Del Giudice E; Cenacchi V; Volta R; Villetti G; Facchinetti F; Riccardi B; Puccini P; Moretto N; Grassi F; Ottonello S; Leon A
Pharmacol Res; 2007 Apr; 55(4):318-28. PubMed ID: 17292621
[TBL] [Abstract][Full Text] [Related]
9. CHF5074, a novel gamma-secretase modulator, attenuates brain beta-amyloid pathology and learning deficit in a mouse model of Alzheimer's disease.
Imbimbo BP; Hutter-Paier B; Villetti G; Facchinetti F; Cenacchi V; Volta R; Lanzillotta A; Pizzi M; Windisch M
Br J Pharmacol; 2009 Mar; 156(6):982-93. PubMed ID: 19239474
[TBL] [Abstract][Full Text] [Related]
10. The γ-secretase modulator CHF5074 reduces the accumulation of native hyperphosphorylated tau in a transgenic mouse model of Alzheimer's disease.
Lanzillotta A; Sarnico I; Benarese M; Branca C; Baiguera C; Hutter-Paier B; Windisch M; Spano P; Imbimbo BP; Pizzi M
J Mol Neurosci; 2011 Sep; 45(1):22-31. PubMed ID: 21181298
[TBL] [Abstract][Full Text] [Related]
11. Electrophysiological and metabolic effects of CHF5074 in the hippocampus: protection against in vitro ischemia.
Mango D; Barbato G; Piccirilli S; Panico MB; Feligioni M; Schepisi C; Graziani M; Porrini V; Benarese M; Lanzillotta A; Pizzi M; Pieraccini S; Sironi M; Blandini F; Nicoletti F; Mercuri NB; Imbimbo BP; Nisticò R
Pharmacol Res; 2014 Mar; 81():83-90. PubMed ID: 24630950
[TBL] [Abstract][Full Text] [Related]
12. CHF5074 protects SH-SY5Y human neuronal-like cells from amyloidbeta 25-35 and tumor necrosis factor related apoptosis inducing ligand toxicity in vitro.
Ronsisvalle N; Di Benedetto G; Parenti C; Amoroso S; Bernardini R; Cantarella G
Curr Alzheimer Res; 2014; 11(7):714-24. PubMed ID: 24938499
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of gamma-secretase and BACE1 inhibition on brain Abeta levels in vitro and in vivo.
Elvang AB; Volbracht C; Pedersen LØ; Jensen KG; Karlsson JJ; Larsen SA; Mørk A; Stensbøl TB; Bastlund JF
J Neurochem; 2009 Sep; 110(5):1377-87. PubMed ID: 19519664
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic effect of CHF5074, a new γ-secretase modulator, in a mouse model of scrapie.
Poli G; Corda E; Lucchini B; Puricelli M; Martino PA; Dall'ara P; Villetti G; Bareggi SR; Corona C; Vallino Costassa E; Gazzuola P; Iulini B; Mazza M; Acutis P; Mantegazza P; Casalone C; Imbimbo BP
Prion; 2012; 6(1):62-72. PubMed ID: 22453180
[TBL] [Abstract][Full Text] [Related]
15. Gamma-Secretase Inhibitors Attenuate Neurotrauma and Neurogenic Acute Lung Injury in Rats by Rescuing the Accumulation of Hypertrophic Microglia.
Lin HJ; Hsu CC; Chio CC; Tian YF; Lin MT; Lin TW; Chang CH; Chang CP
Cell Physiol Biochem; 2017; 44(5):1726-1740. PubMed ID: 29227981
[TBL] [Abstract][Full Text] [Related]
16. Neuropep-1 ameliorates learning and memory deficits in an Alzheimer's disease mouse model, increases brain-derived neurotrophic factor expression in the brain, and causes reduction of amyloid beta plaques.
Shin MK; Kim HG; Baek SH; Jung WR; Park DI; Park JS; Jo DG; Kim KL
Neurobiol Aging; 2014 May; 35(5):990-1001. PubMed ID: 24268884
[TBL] [Abstract][Full Text] [Related]
17. Differential effects between γ-secretase inhibitors and modulators on cognitive function in amyloid precursor protein-transgenic and nontransgenic mice.
Mitani Y; Yarimizu J; Saita K; Uchino H; Akashiba H; Shitaka Y; Ni K; Matsuoka N
J Neurosci; 2012 Feb; 32(6):2037-50. PubMed ID: 22323718
[TBL] [Abstract][Full Text] [Related]
18. Uridine prodrug improves memory in Tg2576 and TAPP mice and reduces pathological factors associated with Alzheimer's disease in related models.
Saydoff JA; Olariu A; Sheng J; Hu Z; Li Q; Garcia R; Pei J; Sun GY; von Borstel R
J Alzheimers Dis; 2013; 36(4):637-57. PubMed ID: 23648515
[TBL] [Abstract][Full Text] [Related]
19. Restoration of dopamine release deficits during object recognition memory acquisition attenuates cognitive impairment in a triple transgenic mice model of Alzheimer's disease.
Guzmán-Ramos K; Moreno-Castilla P; Castro-Cruz M; McGaugh JL; Martínez-Coria H; LaFerla FM; Bermúdez-Rattoni F
Learn Mem; 2012 Sep; 19(10):453-60. PubMed ID: 22984283
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotective and Anti-Apoptotic Effects of CSP-1103 in Primary Cortical Neurons Exposed to Oxygen and Glucose Deprivation.
Porrini V; Sarnico I; Benarese M; Branca C; Mota M; Lanzillotta A; Bellucci A; Parrella E; Faggi L; Spano P; Imbimbo BP; Pizzi M
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28106772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
